Principal Investigator

Fred Hagen, Ph.D. University of Rochester work Box 712 601 Elmwood Ave Rochester NY 14642 office: KMRB G-9828 p 585-275-0336 f 585-276-0190 fred_hagen@urmc.rochester.edu

Personnel

Fred Hagen, Ph.D. University of Rochester

Principal Investigator

work Box 712 601 Elmwood Ave Rochester NY 14642 office: KMRB G-9828 p 585-275-0336 f 585-276-0190 fred_hagen@urmc.rochester.edu Research Focus: Glycosyltransferases, proteomics, role of glycosylation in development

Jennifer Hryhorenko University of Rochester

Technical Associate I

work 601 Elmwood Ave Rochester NY 14642 office: KMRB G-9834 p 585-275-0769 jennifer_hryhorenko@urmc.rochester.edu

Kevin Welle University of Rochester

Technical Associate I

work 601 Elmwood Ave Rochester NY 14642 office: KMRB G-9834 p 585-275-0769 kevin_welle@urmc.rochester.edu

Recent Publications

1. Miralem T
2. Lerner-Marmarosh N
3. Gibbs PE
4. Tudor C
5. Hagen FK
6. Maines MD
(2012 Jul 13). The human biliverdin reductase-based peptide fragments and biliverdin regulate protein kinase Cδ activity: the peptides are inhibitors or substrate for the protein kinase C. J Biol Chem. 287, 24698-712.
1. Wangler NJ
2. Santos KL
3. Schadock I
4. Hagen FK
5. Escher E
6. Bader M
7. Speth RC
8. Karamyan VT
(2012 Jan 02). Identification of membrane-bound variant of metalloendopeptidase neurolysin (EC 3.4.24.16) as the non-angiotensin type 1 (non-AT1), non-AT2 angiotensin binding site. J Biol Chem. 287, 114-22.
1. Hagen FK
(2012 Jan 01). Proteoglycan: site mapping and site-directed mutagenesis. Methods Mol Biol. 836, 23-34.

See all »